← Leaderboards
Philip Todd Korthuis
Oregon Health & Science University
$15,101,791
Attributed
$18,938,623
Total exposure
15
Grants
14
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $6.6M · FY2007–25$10M$7.5M$5M$2.5M$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$35,933,128 · 16
By mechanism
UG1$18,176,386 · 8
R01$5,429,994 · 2
U01$5,151,296 · 1
UH3$3,959,427 · 1
K12$1,005,365 · 1
UG3$895,080 · 1
Top collaborators
- Keith N Humphreys24 shared
- James L. Sorensen15 shared
- April Marie Young5 shared
- Matthew S Freiberg2 shared
- Hilary A. Tindle2 shared
Most similar at Oregon Health & Science University
Same institution · by research overlap
- April Marie Young$9,966,800
- Robert A. Lowe$2,261,298
Others in their field
Top investigators on “Oregon”
- Clare E Reimers · Gordon Research Conferences$207,486,742
- Demian A Bailey · Oregon State University$205,628,026
- James B Edson · Woods Hole Oceanographic Institution$163,686,800
- Albert J Plueddemann · Woods Hole Oceanographic Institution$163,686,800
- Lee Marshall Nadler · Dana-Farber Cancer Inst$138,509,389
- Eric S. Orwoll · Oregon Health And Science University$69,620,607
Research focus
OregonCaringTrainingResearch PersonnelBaseResourcesPersonsClinical Trials NetworkAddictionDrug AbuseHealthcareUniversitiesMedicalSiteCollaborationsProtocols DocumentationProviderClinical TreatmentPublic HealthProgramsServicesClinical TrialsPrimary Health CareDrug Usage
Grant awards (68)
Western States Node of the National Drug Abuse Treatment Clinical Trials Network (TMS for CUD)$1,296,412
UG1 · FY2025 · DA · contact PI
Western States Node of the National Drug Abuse Treatment Clinical Trials Network$815,543
UG1 · FY2025 · DA · contact PI
Peer Engagement in Methamphetamine Harm-Reduction with Contingency Management (PEER-CM)$617,441
R01 · FY2025 · DA · contact PI
Vanderbilt Oregon COllaborative Scholar Training in Addiction Research (COSTAR)$537,839
K12 · FY2025 · DA
Western States Node of the National Drug Abuse Treatment Clinical Trials Network (CTN-139)$314,465
UG1 · FY2025 · DA · contact PI
Western States Node of the National Drug Abuse Treatment Clinical Trials Network (CTN-0149)$241,844
UG1 · FY2025 · DA · contact PI
Western States Node of the National Drug Abuse Treatment Clinical Trials Network$1,077,251
UG1 · FY2024 · DA · contact PI
Vanderbilt Oregon COllaborative Scholar Training in Addiction Research (COSTAR)$467,526
K12 · FY2024 · DA
Project-004$392,559
UG1 · FY2024 · DA · contact PI
Project-005$183,157
UG1 · FY2024 · DA · contact PI
PEER-CM Peripartum Supplement$178,938
R01 · FY2024 · DA · contact PI
Project-003$61,854
UG1 · FY2024 · DA · contact PI
Project-002$23,233
UG1 · FY2024 · DA · contact PI
Peer-based Retention of people who Use Drugs in Rural Research (PROUD-R2)$937,335
U01 · FY2023 · TR · contact PI
Project-002$309,388
UG1 · FY2023 · DA · contact PI
Western States Node of the National Drug Abuse Treatment Clinical Trials Network$178,971
UG1 · FY2023 · DA · contact PI
Project-004$128,864
UG1 · FY2023 · DA · contact PI
Project-003$82,826
UG1 · FY2023 · DA · contact PI
Peer Engagement in Methamphetamine Harm-Reduction with Contingency Management (PEER-CM)$1,936,443
R01 · FY2022 · DA · contact PI
Western States Node of the National Drug Abuse Treatment Clinical Trials Network$747,413
UG1 · FY2022 · DA · contact PI
Medication for Opioid Use Disorder, Predictability of Retention vs Attrition$586,143
UG1 · FY2022 · DA · contact PI
Western States Node of the National Drug Abuse Treatment Clinical Trials Network$308,675
UG1 · FY2022 · DA · contact PI
Oregon HIV/Hepatitis and Opioid Prevention and Engagement (OR-HOPE) Study Cost Extension$153,923
UH3 · FY2022 · DA · contact PI
Using Integrative Data Analysis to Examine the Impact of Psychosocial Treatments for Black Cocaine Users Enrolled in the NIDA Drug Abuse Treatment Clinical Trials Network (CTN)$100,731
UG1 · FY2022 · DA · contact PI
Oregon HIV/Hepatitis and Opioid Prevention and Engagement (OR-HOPE) Study$1,287,430
UH3 · FY2021 · DA · contact PI
Peer-based Retention of people who Use Drugs in Rural Research (PROUD-R2)$1,033,724
U01 · FY2021 · TR · contact PI
Western States Node of the National Drug Abuse Treatment Clinical Trials Network$755,924
UG1 · FY2021 · DA · contact PI
Western States Node of the National Drug Abuse Treatment Clinical Trials Network$522,754
UG1 · FY2021 · DA · contact PI
Western States Node of the National Drug Abuse Treatment Clinical Trials Network$310,654
UG1 · FY2021 · DA · contact PI
Using Integrative Data Analysis to Examine the Impact of Psychosocial Treatments for Black Cocaine Users Enrolled in the NIDA Drug Abuse Treatment Clinical Trials Network (CTN)$97,989
UG1 · FY2021 · DA · contact PI
Oregon HIV/Hepatitis and Opioid Prevention and Engagement (OR-HOPE) Study$1,206,083
UH3 · FY2020 · DA · contact PI
Peer-based Retention of people who Use Drugs in Rural Research (PROUD-R2)$1,056,107
U01 · FY2020 · TR · contact PI
Western States Node of the National Drug Abuse Treatment Clinical Trials Network$1,020,413
UG1 · FY2020 · DA · contact PI
Western States Node of the National Drug Abuse Treatment Clinical Trials Network$915,318
UG1 · FY2020 · DA · contact PI
Western States Node of the National Drug Abuse Treatment Clinical Trials Network$337,878
UG1 · FY2020 · DA · contact PI
Oregon HIV/HCV and Opioid Prevention and Engagement (OR-HOPE)$153,900
UH3 · FY2020 · DA · contact PI
Western States Node of the National Drug Abuse Treatment Clinical Trials Network$2,200,084
UG1 · FY2019 · DA
Oregon HIV/Hepatitis and Opioid Prevention and Engagement (OR-HOPE) Study$1,158,091
UH3 · FY2019 · DA · contact PI
Peer-based Retention of people who Use Drugs in Rural Research (PROUD-R2)$1,081,028
U01 · FY2019 · TR · contact PI
Western States Node of the National Drug Abuse Treatment Clinical Trials Network$797,698
UG1 · FY2019 · DA
Western States Node of the National Drug Abuse Treatment Clinical Trials Network$691,567
UG1 · FY2019 · DA
Western States Node of the National Drug Abuse Treatment Clinical Trials Network$286,011
UG1 · FY2019 · DA
Western States Node of the National Drug Abuse Treatment Clinical Trials Network$142,146
UG1 · FY2019 · DA
Western States Node of the National Drug Abuse Treatment Clinical Trials Network$129,831
UG1 · FY2019 · DA
Western States Node of the National Drug Abuse Treatment Clinical Trials Network$42,027
UG1 · FY2019 · DA
Western States Node of the National Drug Abuse Treatment Clinical Trials Network$36,702
UG1 · FY2019 · DA
Western States Node of the National Drug Abuse Treatment Clinical Trials Network$18,104
UG1 · FY2019 · DA
Peer-based Retention of people who Use Drugs in Rural Research (PROUD-R2)$1,043,102
U01 · FY2018 · TR · contact PI
Western States Node of the National Drug Abuse Treatment Clinical Trials Network$948,068
UG1 · FY2018 · DA
Western States Node of the National Drug Abuse Treatment Clinical Trials Network$873,331
UG1 · FY2018 · DA
Western States Node of the National Drug Abuse Treatment Clinical Trials Network$679,225
UG1 · FY2018 · DA
Buprenorphine to Improve HIV Care Engagement and Outcomes: A Randomized Trial$523,517
R01 · FY2018 · DA · contact PI
Oregon HIV/Hepatitis and Opioid Prevention and Engagement (OR-HOPE) Study$401,402
UG3 · FY2018 · DA · contact PI
Western States Node of the National Drug Abuse Treatment Clinical Trials Network$267,185
UG1 · FY2018 · DA
Western States Node of the National Drug Abuse Treatment Clinical Trials Network$216,387
UG1 · FY2018 · DA
Western States Node of the National Drug Abuse Treatment Clinical Trials Network$37,761
UG1 · FY2018 · DA
Buprenorphine to Improve HIV Care Engagement and Outcomes: A Randomized Trial$555,250
R01 · FY2017 · DA · contact PI
Oregon HIV/Hepatitis and Opioid Prevention and Engagement (OR-HOPE) Study$493,678
UG3 · FY2017 · DA · contact PI
Buprenorphine to Improve HIV Care Engagement and Outcomes: A Randomized Trial$537,302
R01 · FY2016 · DA · contact PI
Buprenorphine to Improve HIV Care Engagement and Outcomes: A Randomized Trial$546,720
R01 · FY2014 · DA · contact PI
Risky Decision-Making in Methamphetamine Users: The Role of Opioid Blockade$192,500
R21 · FY2014 · DA · contact PI
Buprenorphine to Improve HIV Care Engagement and Outcomes: A Randomized Trial$534,383
R01 · FY2013 · DA · contact PI
Risky Decision-Making in Methamphetamine Users: The Role of Opioid Blockade$231,000
R21 · FY2012 · DA · contact PI
Quality Outcomes for Patients with Drug Abuse and HIV$178,416
K23 · FY2011 · DA · contact PI
Quality Outcomes for Patients with Drug Abuse and HIV$178,416
K23 · FY2010 · DA · contact PI
Quality Outcomes for Patients with Drug Abuse and HIV$178,416
K23 · FY2009 · DA · contact PI
Quality Outcomes for Patients with Drug Abuse and HIV$178,416
K23 · FY2008 · DA · contact PI
Quality Outcomes for Patients with Drug Abuse and HIV$178,416
K23 · FY2007 · DA · contact PI